Rosetta Genomics
Discovering, developing, and commercializing next generation diagnostic tests for personalized medicine.
Launch date
Employees
Market cap
AUD45.8k
Enterprise valuation
AUD46k (Public information from Sep 2024)
Share price
$0.0001 ROSGQ
Princeton New Jersey (HQ), Rehovot Center District (founding location)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $2.5m | Post IPO Equity | |
N/A | $2.7m | Post IPO Equity | |
N/A | $1.5m | Post IPO Equity | |
N/A | $1.8m | Post IPO Equity | |
$10.0m Valuation: $10.0m | Acquisition | ||
Total Funding | - |
Recent News about Rosetta Genomics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.